Status and trend analysis of prophylactic usage of recombinant Factor VIII in chinese pediatric patients with hemophilia A: ReCare- A Retrospective, Phase IV, Non-Interventional Study.

CONCLUSION: Our data revealed an overall improvement in the treatment dosage and duration with an increase in the number of patients receiving prophylaxis. The total proportion of rFVIII also increased gradually indicating the development of economy and safety awareness. PMID: 28532239 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/28532239?dopt=Abstract

Source: Current Medical Research and Opinion - May 25, 2017 Category: Research Tags: Curr Med Res Opin Source Type: research